Targeting oncogenic kinases: Insights on FDA approved tyrosine kinase inhibitors
Article in European Journal of Pharmacology (March 2024)
The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.
Article in European Journal of Pharmacology (March 2024)
Article in Journal of Cancer (January 2024)
Article in Cellular & Molecular Immunology (December 2023)